CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in number of people suffering from diabetes
3.4.1.2. Benefits of CGMs over conventional glucose monitoring devices
3.4.1.3. High adoption rate of CGMs in home healthcare and ICUs
3.4.2. Restraints
3.4.2.1. Adverse effects associated with CGMs
3.4.2.2. High cost of CGMs
3.4.3. Opportunities
3.4.3.1. High undiagnosed patient population
3.4.3.2. Technological advancement in CGMs
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT
4.1. Overview
4.1.1. Market size and forecast
4.2. Sensors
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Transmitters and Receivers
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY
5.1. Overview
5.1.1. Market size and forecast
5.2. Child Population
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Adult Population
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
CHAPTER 6: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospital and Clinics
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Home healthcare
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Component
7.2.3. Market size and forecast, by Demography
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Component
7.2.5.1.3. Market size and forecast, by Demography
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Component
7.2.5.2.3. Market size and forecast, by Demography
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Component
7.2.5.3.3. Market size and forecast, by Demography
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Component
7.3.3. Market size and forecast, by Demography
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Component
7.3.5.1.3. Market size and forecast, by Demography
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Component
7.3.5.2.3. Market size and forecast, by Demography
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Component
7.3.5.3.3. Market size and forecast, by Demography
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Component
7.3.5.4.3. Market size and forecast, by Demography
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Russia
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Component
7.3.5.5.3. Market size and forecast, by Demography
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Spain
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Component
7.3.5.6.3. Market size and forecast, by Demography
7.3.5.6.4. Market size and forecast, by End User
7.3.5.7. Netherlands
7.3.5.7.1. Key market trends, growth factors and opportunities
7.3.5.7.2. Market size and forecast, by Component
7.3.5.7.3. Market size and forecast, by Demography
7.3.5.7.4. Market size and forecast, by End User
7.3.5.8. Norway
7.3.5.8.1. Key market trends, growth factors and opportunities
7.3.5.8.2. Market size and forecast, by Component
7.3.5.8.3. Market size and forecast, by Demography
7.3.5.8.4. Market size and forecast, by End User
7.3.5.9. Sweden
7.3.5.9.1. Key market trends, growth factors and opportunities
7.3.5.9.2. Market size and forecast, by Component
7.3.5.9.3. Market size and forecast, by Demography
7.3.5.9.4. Market size and forecast, by End User
7.3.5.10. Denmark
7.3.5.10.1. Key market trends, growth factors and opportunities
7.3.5.10.2. Market size and forecast, by Component
7.3.5.10.3. Market size and forecast, by Demography
7.3.5.10.4. Market size and forecast, by End User
7.3.5.11. Finland
7.3.5.11.1. Key market trends, growth factors and opportunities
7.3.5.11.2. Market size and forecast, by Component
7.3.5.11.3. Market size and forecast, by Demography
7.3.5.11.4. Market size and forecast, by End User
7.3.5.12. Rest of Europe
7.3.5.12.1. Key market trends, growth factors and opportunities
7.3.5.12.2. Market size and forecast, by Component
7.3.5.12.3. Market size and forecast, by Demography
7.3.5.12.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Component
7.4.3. Market size and forecast, by Demography
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Component
7.4.5.1.3. Market size and forecast, by Demography
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Component
7.4.5.2.3. Market size and forecast, by Demography
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Component
7.4.5.3.3. Market size and forecast, by Demography
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Component
7.4.5.4.3. Market size and forecast, by Demography
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Component
7.4.5.5.3. Market size and forecast, by Demography
7.4.5.5.4. Market size and forecast, by End User
7.4.5.6. New Zealand
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Component
7.4.5.6.3. Market size and forecast, by Demography
7.4.5.6.4. Market size and forecast, by End User
7.4.5.7. Philippines
7.4.5.7.1. Key market trends, growth factors and opportunities
7.4.5.7.2. Market size and forecast, by Component
7.4.5.7.3. Market size and forecast, by Demography
7.4.5.7.4. Market size and forecast, by End User
7.4.5.8. Rest of Asia-Pacific
7.4.5.8.1. Key market trends, growth factors and opportunities
7.4.5.8.2. Market size and forecast, by Component
7.4.5.8.3. Market size and forecast, by Demography
7.4.5.8.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Component
7.5.3. Market size and forecast, by Demography
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Component
7.5.5.1.3. Market size and forecast, by Demography
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Component
7.5.5.2.3. Market size and forecast, by Demography
7.5.5.2.4. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Component
7.5.5.3.3. Market size and forecast, by Demography
7.5.5.3.4. Market size and forecast, by End User
7.5.5.4. Venezuela
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Component
7.5.5.4.3. Market size and forecast, by Demography
7.5.5.4.4. Market size and forecast, by End User
7.5.5.5. Argentina
7.5.5.5.1. Key market trends, growth factors and opportunities
7.5.5.5.2. Market size and forecast, by Component
7.5.5.5.3. Market size and forecast, by Demography
7.5.5.5.4. Market size and forecast, by End User
7.5.5.6. Rest of LAMEA
7.5.5.6.1. Key market trends, growth factors and opportunities
7.5.5.6.2. Market size and forecast, by Component
7.5.5.6.3. Market size and forecast, by Demography
7.5.5.6.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. Medtronic plc
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. Abbott Laboratories
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. DexCom, Inc.
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Senseonics
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Key strategic moves and developments
9.5. Johnson & Johnson
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.6. A. Menarini Diagnostics S.r.l
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. Novo Nordisk A/S
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.8. GlySens Incorporated
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. Ypsomed AG
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.9.6. Business performance
9.10. F. Hoffman-La Roche Ltd
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
TABLE 01. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 02. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR SENSORS , BY REGION, 2021-2031 ($MILLION)
TABLE 03. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR TRANSMITTERS AND RECEIVERS , BY REGION, 2021-2031 ($MILLION)
TABLE 04. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 05. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR CHILD POPULATION, BY REGION, 2021-2031 ($MILLION)
TABLE 06. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR ADULT POPULATION, BY REGION, 2021-2031 ($MILLION)
TABLE 07. GLOBAL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 08. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOSPITAL AND CLINICS, BY REGION, 2021-2031 ($MILLION)
TABLE 09. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR HOME HEALTHCARE, BY REGION, 2021-2031 ($MILLION)
TABLE 10. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 11. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 12. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 13. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 14. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 15. NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 16. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 17. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 18. U.S. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 19. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 20. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 21. CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 22. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 23. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 24. MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 25. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 26. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 27. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 28. EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 29. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 30. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 31. GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 32. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 33. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 34. FRANCE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 35. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 36. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 37. UK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 38. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 39. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 40. ITALY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 41. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 42. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 43. RUSSIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 44. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 45. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 46. SPAIN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 47. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 48. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 49. NETHERLANDS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 50. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 51. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 52. NORWAY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 53. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 54. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 55. SWEDEN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 56. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 57. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 58. DENMARK CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 59. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 60. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 61. FINLAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 62. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 63. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 64. REST OF EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 65. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 66. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 67. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 68. ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 69. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 70. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 71. JAPAN CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 72. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 73. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 74. CHINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 75. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 76. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 77. INDIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 78. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 79. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 80. AUSTRALIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 81. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 82. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 83. SOUTH KOREA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 84. NEW ZEALAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 85. NEW ZEALAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 86. NEW ZEALAND CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 87. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 88. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 89. PHILIPPINES CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 90. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 91. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 92. REST OF ASIA-PACIFIC CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 93. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 94. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 95. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 96. LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 97. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 98. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 99. BRAZIL CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 100. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 101. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 102. SAUDI ARABIA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 103. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 104. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 105. SOUTH AFRICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 106. VENEZUELA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 107. VENEZUELA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 108. VENEZUELA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 109. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 110. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 111. ARGENTINA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 112. REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY COMPONENT, 2021-2031 ($MILLION)
TABLE 113. REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY DEMOGRAPHY, 2021-2031 ($MILLION)
TABLE 114. REST OF LAMEA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 115. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 116. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 117. MEDTRONIC PLC: PRODUCT SEGMENTS
TABLE 118. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 119. MEDTRONIC PLC: KEY STRATERGIES
TABLE 120. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 121. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 122. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 123. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 124. ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 125. DEXCOM, INC.: KEY EXECUTIVES
TABLE 126. DEXCOM, INC.: COMPANY SNAPSHOT
TABLE 127. DEXCOM, INC.: PRODUCT SEGMENTS
TABLE 128. DEXCOM, INC.: PRODUCT PORTFOLIO
TABLE 129. DEXCOM, INC.: KEY STRATERGIES
TABLE 130. SENSEONICS: KEY EXECUTIVES
TABLE 131. SENSEONICS: COMPANY SNAPSHOT
TABLE 132. SENSEONICS: PRODUCT SEGMENTS
TABLE 133. SENSEONICS: PRODUCT PORTFOLIO
TABLE 134. SENSEONICS: KEY STRATERGIES
TABLE 135. JOHNSON & JOHNSON: KEY EXECUTIVES
TABLE 136. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 137. JOHNSON & JOHNSON: PRODUCT SEGMENTS
TABLE 138. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 139. A. MENARINI DIAGNOSTICS S.R.L: KEY EXECUTIVES
TABLE 140. A. MENARINI DIAGNOSTICS S.R.L: COMPANY SNAPSHOT
TABLE 141. A. MENARINI DIAGNOSTICS S.R.L: PRODUCT SEGMENTS
TABLE 142. A. MENARINI DIAGNOSTICS S.R.L: PRODUCT PORTFOLIO
TABLE 143. NOVO NORDISK A/S: KEY EXECUTIVES
TABLE 144. NOVO NORDISK A/S: COMPANY SNAPSHOT
TABLE 145. NOVO NORDISK A/S: PRODUCT SEGMENTS
TABLE 146. NOVO NORDISK A/S: PRODUCT PORTFOLIO
TABLE 147. GLYSENS INCORPORATED: KEY EXECUTIVES
TABLE 148. GLYSENS INCORPORATED: COMPANY SNAPSHOT
TABLE 149. GLYSENS INCORPORATED: PRODUCT SEGMENTS
TABLE 150. GLYSENS INCORPORATED: PRODUCT PORTFOLIO
TABLE 151. YPSOMED AG: KEY EXECUTIVES
TABLE 152. YPSOMED AG: COMPANY SNAPSHOT
TABLE 153. YPSOMED AG: PRODUCT SEGMENTS
TABLE 154. YPSOMED AG: PRODUCT PORTFOLIO
TABLE 155. F. HOFFMAN-LA ROCHE LTD: KEY EXECUTIVES
TABLE 156. F. HOFFMAN-LA ROCHE LTD: COMPANY SNAPSHOT
TABLE 157. F. HOFFMAN-LA ROCHE LTD: PRODUCT SEGMENTS
TABLE 158. F. HOFFMAN-LA ROCHE LTD: PRODUCT PORTFOLIO
